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Objective: Pooled bronchoalveolar lavage fluid (BALF), the return of lavage, contains both bronchial and 
alveolar material which differ from each other. Artifacts may be created by filtering, centrifuging and washing 
cells before cytopreparation. This study presents reference values of healthy volunteers for the alveolar 
sample, ALF, cytopreparation being performed without filtration or centrifugation. 
Methods: Eighteen healthy, non-smoking volunteers underwent a standard bronchoalveolar lavage using 10 
aliquots of 20 ml of saline. Excluding the return of the first and second aliquots, the rest were pooled and 
examined cytologically, immunocytochemically and biochemically. The mean, standard deviation, and 95% 
confidence limits were calculated for the following variables: amount of return, estimated content of epithelial 
lining fluid (ELF), total and differential cell counts on filter and cytocentrifuge (CCF) preparations, computed 
cell counts per unit volume of ALF, distribution of lymphocyte subgroups CD3+CD2, CD4, CD8, CD19, 
CD25 and CD57, and the ratio of CD4 to CD8, the amounts of lymphocytes in the same subgroups per 
volume of ALF, and the concentrations of total protein, albumin, immunoglobulins A, G and M, hyaluronic 
acid, eosinophilic cationic protein (ECP), procollagen III aminoterminal propeptide (PCP) and 
&-microglobulin in ALF and in ELF, as well as the ratios of the concentrations of the solutes in ALF to the 
same in serum. 
Results: The 95% confidence limits of means for the most important variables were as follows: estimated 
ELF content 0.42-0.74%; total cells in ALF 76.6-143.0 x 10” 1~ ‘; distribution of inflammatory cells on filter 
and CCF slides: macrophages 74.9-83.6 and 81490.1%, lymphocytes 13.1-22.5 and 8.1-16.4%, and 
neutrophils 1.0-4.1 and 0.7-2.7”/0, respectively; distribution of lymphocyte subsets: CD3 + CD2 85690.6%, 
CD4 44.3-53.1%, CD8 26.9935.80/o; concentration of solutes in ALF: total protein 44.8-61.3 mg 1~ ‘, albumin 
154-22.2 mg 1~ ’ , IgA 1.8-3.4 mg 1~ ‘, IgG 3.1-6.1 mg 1~ ‘, IgM 0.05-0.26 mg 1~ ‘, hyaluronic acid 
8.8-l 1.1 pg 1.. ’ . ECP 0.19-0.77 pg 1~ ’ , PCP 0.005-0.058 pg I ’ , &-microglobulin 62.2-8 1.5 pg 1~ ’ . 
Conclusions: Our results show that excluding the bronchial sample from ALF of volunteer subjects 
and omitting filtering and washing before cytopreparation produces cytologic, immunocytochemical and 
biochemical reference values with reasonable 95% confidence limits to be used in clinical settings. 
Introduction 
Lung lavage is commonly used to harvest cellular 
and chemical material from the respiratory paren- 
chyma of the lung for research and diagnosis of 
interstitial pulmonary diseases (1). Bronchoalveolar 
lavage fluid (BALF), the return of lavage, repre- 
sents the contents of both peripheral conducting 
airways and alveoli. The return of the first part, the 
bronchial sample, comes mainly from conducting 
airways while the rest, the alveolar sample, repre- 
sents the contents of alveoli (2). The cellular profiles 
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of bronchial and alveolar samples differ significantly 
from each other (3). Thus, reference values for 
pooled BALF are apparently not valid for the 
alveolar sample, alveolar lavage fluid (ALF). Un- 
fortunately, very few studies exist in which this 
distinction has been made. 
In pooled BALF there is often bronchial mucus 
which gives a disturbing background in cytocentri- 
fuge (CCF) preparations. Many laboratories, there- 
fore, filter BALF through gauze, separate cells from 
supernatant by centrifugation, and wash the cells 
before making CCF slides (4); sometimes even total 
cell count has been made after these procedures (5). 
Saltini et al. (6) and Mordelet-Dambrine et al. (7) 
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showed that washing destroys an unpredictable 
amount and variety of cells, and Lam et al. (8) 
observed that even filtering through gauze signifi- 
cantly decreases the total recovery of cells in BALF. 
A little later, Willcox et al. (9) demonstrated that 
mere centrifugation with resuspension causes a gen- 
eralized loss of cells. Nevertheless, the routine of 
filtering and centrifuging pooled BALF is still in 
common use, especially in immunocytochemical 
studies (4). 
BALF also contains a large amount of active 
soluble substances (4), but the significance of them is 
problematic because a reliable method for the deter- 
mination of the so-called dilution factor does not 
exist (10). We, however, have demonstrated signifi- 
cant differences in the concentration of several pro- 
teins in lavage fluid between healthy controls and 
patients with interstitial lung diseases (1 l), as well as 
differences of the same associated with the activity of 
sarcoidosis (12). Rennard et al. (2) observed consid- 
erable differences in the concentrations of several 
proteins between bronchial and alveolar samples of 
both normal volunteers and patients. However, most 
biochemical reference values published so far have 
been determined on pooled BALF (4). Although 
the proportion of bronchial material in BALF is 
relatively small, it may still significantly increase the 
existing confusion. 
In our laboratory the bronchial sample is separ- 
ated from ALF which is not filtered nor centrifuged 
before cytopreparation. In this article we describe 
the method and give some cytologic, immuno- 
cytochemical and biochemical reference values for 
ALF obtained by lavaging a group of healthy 
non-smoking volunteers. 
Materials and Methods 
STUDY SUBJECTS 
The material consisted of 18 healthy volunteers, 10 
men and eight women, with a mean age of 33.4 years 
(SD 8.3 years), who used no drugs, had a normal 
result in spirometry and no skin reactivity, nor 
showed any bronchial obstruction or hyperreactivity 
to histamine. All were lifetime non-smokers. For 
some immunocytochemical studies CCF prep- 
arations from the specimens of only 14 or 13 subjects 
were available (Tables 4 and 5) because the supply 
had been inadvertently exhausted, i.e. in some cases 
too many CCF preparations had been inadvertently 
used for technical testing purposes. All subjects had 
given their informed consent before participation, 
and the study has been approved by the Ethics 
Committee at Mjolbolsta Hospital. 
STUDY DESIGN 
A standard bronchoalveolar lavage was performed 
on each subject and the fluid recovered was examined 
cytologically, immunocytochemically and biochemi- 
cally, and the mean, standard deviation, and 95% 
confidence limits of the mean were calculated for 
each variable. The variables determined were as 
follows: amount of return, estimated content of epi- 
thelial lining fluid (ELF) by urea method (13), total 
and differential cell counts on filter and CCF prep- 
arations, computed cell counts per unit volume of 
ALF, distribution of lymphocytes with surface 
markers for CD3+CD2, CD4, CD8, CD19, CD25, 
CD57 and the ratio of CD4 to CD8, as well as the 
amounts of the same per volume of ALF, and the 
concentrations of total protein, albumin, immuno- 
globulins A, G and M, hyaluronic acid, eosinophilic 
cationic protein (ECP), procollagen III aminotermi- 
nal propeptide (PCP) and &microglobulin in ALF 
and ELF, as well as the ratios of the concentrations 
of the solutes in ALF to the same in serum. 
METHODS 
Lavage protocol 
BAL was performed as recommended by the 
European Task Group on BAL (4). The night before 
lavage the subjects received diazepam 10 mg p.o., and 
l-l.5 h prior to the investigation diazepam 10 mg, 
atropine 0.5 mg, pethidine 50 mg, glycopyrrobromide 
0.2 mg, and chlobutinol hydrochloride 20 mg were 
given i.m. for premeditation. Immediately before 
lavage 10 ml of 2% lidocaine were given via intermit- 
tent positive pressure breathing. After local anaesthe- 
sia of the pharynx, larynx and trachea with 2% 
lidocaine, examination of the airways was carried 
out with a flexible, fibre optic bronchoscope. When 
necessary, lidocaine was also given also via the bron- 
choscope and removed immediately with suction. 
After general inspection of the airways, a sub- 
segment of the right middle lobe was lavaged. With 
the end of the bronchoscope wedged, an aliquot of 
20 ml of sterile 0.9% NaCl at 37.5”C was instilled 10 
times. The effluent was aspirated manually by gentle 
suction using a syringe. 
The fluid recovered from the first and second 
aliquots (bronchial sample) was excluded from the 
study. The other aliquots (ALF) were pooled and 
examined. All fluid recovered was sent to the lab- 
oratory in an ice-bath without preservative and 
processed immediately, always within half an hour. 
Cytologic methods 
ALF was mixed thoroughly but gently. The total 
number of cells per ,~l and % of viable cells were 
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counted in a Btirker haemocytometer after staining 
with 0.02% trypan blue (exclusion test) directly from 
ALF without former centrifugation or resuspension. 
Then 1 ml of ALF was fixed in an equal amount of 
95% ethanol and a Millipore filter preparation was 
made and stained according to Papanicolaou. 
The amount of ALF used for CCF specimens was 
directed by the total amount of cells so that a 
monolayer of a total of about 100 000 cells was 
spread on each CCF slide. The slides were prepared 
in a Cyto-Tek cytocentrifuge (Ames Division, Miles 
Laboratories, Elkhart, Indiana 46515, U.S.A.) at 
900 rpm for 7 min, air-dried overnight in room tem- 
perature, protected from dust, and stained with May- 
Griinwald-Giemsa. 
For differential counts 200 cells were counted on 
filter preparations and 400 cells on CCF slides. 
Epithelial cells were counted on filter preparations 
and their number was subtracted from the total count 
before calculating the differentials of the inflam- 
matory cells. Epithelial cells were omitted when 
counting cells on CCF slides. 
Immunocytochemical methods 
After air-drying, CCF slides for immunocyto- 
chemistry were fixed in acetone at - 20°C for 10 min 
and stored at - 70°C until used. Primary antisera 
(Becton-Dickinson Immunocytometry Systems, San 
Jose, California 95131-1807, U.S.A.) included Anti- 
Leu-4+Anti-Leu-5b (CD3+CD2), Anti-Leu-3a+3b 
(CD4), Anti-Leu2a (CD8), Anti-Leu2a (CD8), 
Anti-Leu-12 (CD19), Anti-Leu-7 (CD57, and Anti- 
Interleukin-2 Receptor (CD25). Immunostaining 
of CCF slides was performed using the Vectastain 
ABC kit (Vector Laboratories, Burlingame, 
California 94010, U.S.A.). Briefly, the slides were 
incubated in a moist chamber at room temperature in 
(1) normal horse serum for 20 min; (2) in primary 
antiserum for 60 min; (3) in biotinylated secondary 
antiserum for 30 min; and (4) in avidin-biotin com- 
plex for 45 min. After steps 24 the slides were 
washed in phosphate buffered saline. Visualization 
was performed with diaminobenzidine using the 
Vector PK 4002 Kit (Vector Laboratories), and 
finally, the slides were counterstained with Mayer’s 
haematoxylin and covered using a normal mounting 
medium (Permount, Fisher Scientific, Fair Lawn, 
New Jersey 07410, U.S.A.). 
Biochemical methods 
After separating the cytologic samples the rest of 
ALF was filtered through gauze and centrifuged at 
4°C 1000 rpm for 10 min. All biochemical determina- 
tions were performed from the ALF supernatant and 
the serum of each subject. 
Urea was determined by an enzymatic method 
with a spectrophotometer using the BUN reagent 
provided by Ciba-Corning, Gilford Systems (Oberlin, 
Ohio 44074, U.S.A.). The apparent epithelial lining 
fluid content (ELF) in ALF was evaluated by means 
of the ratio of the urea content of ALF to that of 
serum (12). For total protein 5 ml of ALF supema- 
tant and 2 ml of 20% trichloracetic acid were centri- 
fuged and a biuret reaction was performed on the 
sediment. Albumin was determined in a Behring 
Nephelometer 100 (Behringwerke Aktiengesellschaft, 
Marburg, Germany) using a procedure recom- 
mended by the manufacturer for microalbumin in 
urine, and immunoglobulins A, G and M in Behring 
Nephelometer 100 using a procedure recommended 
for cerebrospinal fluid, with a IO-fold concentration, 
if necessary, in a Minicon Macrosolute Concentrator 
(Amicon, Danvers, Minnesota 61923, U.S.A.). 
Hyaluronic acid was determined using the Pharmacia 
HA Test 50 RIA kit (Pharmacia Diagnostics AB, 
S-75182 Uppsala, Sweden) modified for 200~1 
of ALF, eosinophil cationic protein using the 
Pharmacia ECP RIA kit, procollagen III amino- 
terminal propeptide using the Orion Diagnostica 
Farmos kit (Orion-Yhtyma Oy, Orion Diagnostica, 
SF-02101 Espoo, Finland) modified for 400~1 of 
ALF, and &microglobulin was determined using the 
Pharmacia &micro RIA kit, modified for low 
concentrations. 
Statistical methods 
The means, standard deviations and 95% confi- 
dence limits of means for each variable, as well as 
Wilcoxon signed rank-tests for significance of differ- 
ences between results of filter and CCF preparations 
were computed using the statistical package SOLO 
(BMDP Statistical Software, Inc, Los Angeles, 
California, U.S.A.) in an Osborne MiStation 3S 
computer (Osborne Computer, Espoo, Finland). A 
nonparametric test was used because BAL data are 
not normally distributed (14). 
Results 
There were no complications. The numeric results 
are presented in Tables 1-8. The proportion of 
monocytes was so small on both filter and CCF 
preparations (means: 0.08% and 0.69%, respectively) 
that they were included in macrophages. The propor- 
tion and number of monocytes per volume of 
macrophages were smaller on filter than on CCF 
preparations (Wilcoxon test, P=O.OOlO and P= 
0.0007, respectively), and the same of lymphocytes 
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Table 1 Means, standard deviations and 95% confidence limits of means for lavage return, 
ELF content, total cells in ALF and ELF, and proportions of living cells and epithelial cells in 
ALF from 18 healthy non-smoking volunteers 
Variable Unit Mean SD 95% confidence limits 
Lavage 
Total return 
Estimated ELF content 
Total cell count 
in ALF 
in ELF 
Viable cells 
Epithelial cells 
ml 200 
ml 171.1 
%;I 86.0 
ml 1.0 
%, 0.59 
15.1 163.6-178.6 
7.3 82.0-89.1 
0.64 0.71-1.3 
0.34 0.43-0.76 
x 1061-’ 107.7 70.3 72.7-142.6 
x 10”1-’ 219.1 135.3 151.9-286.4 
‘% 87.2 7.0 83.7-90.7 
‘%I 3.2 2.2 2.14-3 
ALF, alveolar lavage fluid, alveolar sample of bronchoalveolar lavage return: 
ELF, epithelial lining fluid, estimated by urea method (10). 
Table 2 Means, standard deviations and 95% confidence limits of means for distribution of 
inflammatory cells in ALF from 18 healthy non-smoking volunteers 
Variable Unit Mean SD 95% confidence limits 
Filter preparation, Papanicolaou stain 
Macrophages” o/D 78.5 8.7 
Lymphocytes ‘I/o 184 9.6 
Neutrophils ‘%I 2.7 3.2 
Eosinophils o/u 0.41 0.53 
CCF-preparation, MGG-stain 
Macrophages” ‘% 85.3 9.0 
Lymphocytes ‘X 12.6 8.6 
Neutrophils ‘% 1.7 2.1 
Eosinophils ‘% 0.35 0.62 
Mast cells ‘% 0.08 0.16 
74.2-82.8 
13.7-23.2 
1’ l-4.3 
0.14-0.67 
80.8-89.8 
8.3-16.9 
0.662.8 
0.04-0.66 
0.00-o. 16 
ALF, alveolar lavage fluid, alveolar sample of bronchoalveolar lavage return; 
CCF, cytocentrifuge; MGG, May-Grtinwald-Giemsa; a, including monocytes. 
were larger on filter than on CCF preparations 
(P=O.OOlS and P=O.O017, respectively). 
Discussion 
In this report we give reference values for some 
common cytologic, immunocytochemical and bio- 
chemical variables of the alveolar sample of BALF, 
which we call alveolar lavage fluid (ALF), deter- 
mined on 18 healthy non-smoking volunteers using a 
standard technique of lavaging (4) and handling of 
the specimen with the least possible damage to the 
cells. Despite a trend to standardize the procedures, 
reference values from different laboratories are not 
directly comparable because significant technical 
variations still exist. Although the deleterious effects 
of filtration (8) and centrifugation before cyto- 
preparation (9) have been clearly demonstrated, the 
procedures are still commonly used (4). Similarly, 
although significant differences have been demon- 
strated in cell differentials between bronchial and 
alveolar samples in patients with interstitial diseases 
(15) and in healthy controls (2,3), examination of 
pooled BALF continues in many centres. In fact, 
we have not found a directly comparable report of 
reference values for ALF in the literature, in which 
all these technical pitfalls would have been avoided. 
Even a very comprehensive recent study on BAL 
cellularity in normal volunteers has been performed 
on pooled BALF using conventional methods (14). 
According to our experience, filtration and centrifu- 
gation before cytopreparation of ALF are not 
needed in order to get rid of mucus if the return of 
both first and second aliquots are separated from 
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Table 3 Means, standard deviations and 95% confidence limits of means for amounts of 
inflammatory cells per volume of ALF from 18 healthy non-smoking volunteers 
Variable Unit Mean SD 95% confidence limits 
Filter preparation, Papanicolaou stain 
Macrophages” x 10611’ 
Lymphocytes x 10611’ 
Neutrophils x 1061-’ 
C%$~l%%on, MGG-stain ’ lo6 ’ ’ 
83.6 562 55.7-l 11.5 
21.1 16-5 12.9-29.3 
2.5 3.0 1%4.0 
0.33 0.59 0.04-0.63 
Macrophages” 
Lymphocytes 
Neutrophils 
Eosinophils 
Mast cells 
x 1061-’ 92.3 64.0 60-5-124.1 
x 1061-’ 13.4 10.7 8-l-18.7 
x 10611’ 1.6 1.6 0.79-2.4 
x 10611’ 0.28 0.57 -0.01X).56 
x 1061-’ 0.06 0.24 - 0.060.17 
ALF, alveolar lavage fluid, alveolar sample of bronchoalveolar lavage return; 
CCF, cytocentrifuge; MGG, May-Griinwald-Giemsa; ‘, including monocytes. 
Table 4 Means, standard deviations and 95% confidence limits of means for distribution of 
lymphocytes with different surface markers in ALF from healthy non-smoking volunteers 
Variable (CD class) Unit Mean SD 95”/;1 confidence limits 
(n= 18) 
T cells (CD3 + CD2) ‘S 88.0 5.2 854-90.6 
T helper cells (CD4) ‘%I 49.0 9.2 44 453.6 
T suppressor cells (CD81 ‘Pi 30.9 9.3 26.3-35.6 
CD4/CD8 ratio 1.7 0.6 1.5-2.0 
(n= 13)” 
B cells (CD19) ‘%I 2.1 0.9 1.62.7 
Natural killer (NK) cells (CD57) ‘I/o 10.3 4.3 7.7-13.0 
(n=14) 
IL2-receptor positive cells (CD25) % 6.4 2.7 4.9-7.9 
ALF, alveolar lavage fluid, alveolar sample of bronchoalveolar lavage return; 
IL-2, interleukin 2; a, number of patients smaller than total because the supply of CCF 
preparations was inadvertently exhausted. 
the rest. Even lymphocyte surface markers may 
be demonstrated without filtering or washing the 
cells. However, after taking all samples for cytology 
we separate the supernatant by centrifuging, and 
filter it before biochemical determinations in 
order to protect the capillary tubing of automatic 
analysers. 
In cytology, we have made both millipore filtra- 
tion with Papanicolaou staining and CCF prep- 
arations with May-Griinwald-Giemsa staining. 
Saltini et al. (6) considered filtration more accurate 
than CCF but Thompson et al. (16) showed that 
filtration may underestimate the number of neutro- 
phils. Wilcox et al. (9) did not observe a significant 
difference between millipore filter and CCF prep- 
arations in cell differentials if serum was not added 
before making cytospins, and they considered the 
more expensive filter preparations unnecessary. In 
our material there were significantly more lympho- 
cytes and less mononuclear phagocytes on filter 
than on CCF preparations. The same observation 
was made by Taskinen et al. (S), who used the same 
technique in millipore filtration as us, although their 
CCF preparations were made after filtration and 
washing. We also did not make esterase staining on 
either preparation to distinguish immature macro- 
phages from large lymphocytes which may be 
confused on Papanicolaou stained filters. Taskinen 
et al. concluded that both millipore filtration and 
CCF preparations have advantages that comple- 
ment each other (5). On millipore filter, however, 
the interpretation of lymphocytosis must be 
more cautious than in CCF preparations. Recently, 
Moumouni et al. have suggested that lymphocyte 
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Table 5 Means, standard deviations and 95% confidence limits of means for amounts of 
lymphocytes with different surface markers per volume of ALF from healthy non-smoking 
volunteers 
Variable (CD class) Unit Mean SD 95% confidence limits 
(n= 18) 
T cells (CD3+CD2) x 1061-’ 12.0 9.8 7.1-16.9 
T helper cells (CD4) x 1061-’ 7.0 6.2 3.9-10.1 
T suppressor cells VW x 10611’ 4.3 4-o 2.3-63 
(n=l3) 
B cells (CD19) x 1061-’ 0.36 0.31 0.17-0.54 
Natural killer (NK) cells (CD57) x 10611’ 1.6 1.2 0.90-2.3 
(n=14)” 
ILZ-receptor positive cells (CD25) x 1061-’ 0.96 1.2 0.29-1.6 
ALF, alveolar lavage fluid, alveolar sample of bronchoalveolar lavage return; 
IL-2, interleukin 2; a, number of patients smaller than total because the supply of CCF 
preparations was inadvertently exhausted. 
Table 6 Means, standard deviations and 95% confidence limits of means for some biochemical 
variables in ALF from 18 healthy non-smoking volunteers 
Variable Unit Mean SD 95% confidence limits 
Urea 
Total protein 
Albumin 
Immunoglobulin A 
Immunoglobulin G 
Immunoglobulin M 
Hyaluronic acid 
Eosinophil cationic protein 
Procollagen III propeptide 
&microglobulin 
mM1-l 0.036 0.024 0.024-0.048 
mgl-’ 53.6 17.4 45.0-62.3 
mgll’ 18.8 7.2 15.3-22.4 
mgl-’ 2.7 1.6 193.5 
mgl-’ 4.8 3.1 3.3-6.4 
mgl-’ 0.11 0.32 - 0.05-0.27 
PugI-’ 9.8 2.4 8610.9 
PugI-’ 0.49 0.62 0.194.80 
Hz-’ 0.028 0.067 - 0.005-0.061 
/Gz-’ 72.6 20.4 62.482.7 
ALF, alveolar lavage fluid, alveolar sample of bronchoalveolar lavage return. 
Table 7 Means, standard deviations and 95% confidence limits of means for some biochemical 
variables in ELF from 18 healthy non-smoking volunteers 
Variable Unit Mean SD 95% confidence limits 
Total protein 
Albumin 
Immunoglobulin A 
Immunoglobulin G 
Immunoglobulin M 
Hyaluronic acid 
Eosinophil cationic protein 
Procollagen III propeptide 
&microglobulin 
g1-’ 10.7 4.5 8.5-12.9 
g1r’ 3.8 1.9 2.94.7 
mgll’ 57 42 3678 
glr’ 0.89 0.66 0.56-1.22 
mgll’ 28 83 - 13-69 
mgll’ 2-l 1.1 162.6 
I%-’ 89 65 57-121 
Pgl-’ 5 12 - l-l 1 
mgll’ 15.2 7.7 11.3319.1 
ELF, epithelial lining fluid, estimated by urea method (10). 
loss from CCF slides could arise from poor adher- In two studies on healthy volunteers with com- 
ence on slides, exacerbated during aqueous staining parable, although not identical, technique (2,3), the 
if no artifice is used to hold them (17). distributions of main cytologic variables in ALF did 
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Table 8 Means, standard deviations and 95% confidence limits of means for ratios of some biochemical variables in ALF 
to the same in serum from 18 healthy non-smoking volunteers 
Variable Units Coefficient Mean SD 95% confidence limits 
ALFlserum urea, 
ALF/serum total protein 
ALFlserum albumin 
ALFlserum immunoglobulin A 
ALF/serum immunoglobulin G 
ALF/serum immunoglobulin M 
ALFlserum hyaluronic acid 
ALF/serum ECP 
ALFlserum PCP 
ALFlserum &microglobulin 
rnM.1~ l/rnMd ’ 
mg.1 - l/g1 - ’ 
mg.1 - l/g1 - ’ 
mg.1 - ‘/gl - ’ 
rng.1~ l/g1 ’ 
mg.1 - l/g,1 - ’ 
pg.1 ‘/pg.1 ’ 
pg.1 ‘/pg.1 ’ 
fig1 ‘/,,gd ’ 
pg.1 ‘/mg.l ’ 
x 1o-2 0.64 0.33 0.48%0.8 1 
x 10-x 0.77 0.25 0.640.89 
x 10-S 0.48 0.20 0.384.58 
x 10-X 1.45 1.08 0.91L1.99 
x 10-j 0.40 0.26 0.27-0.52 
x 10-X 0.093 0.29 - 0.050-0.23 
Xl 0.97 0.58 0.68-1.26 
Xl 0.078 0.09 1 0.033-0.12 
x 10-2 1.0 2.49 2.00-2.27 
x lo-’ 53.3 20.3 43.2-63.3 
ALF, alveolar lavage fluid, alveolar sample of bronchoalveolar lavage return; 
ECP, eosinophil cationic protein; PCP, procollagen III aminoterminal propeptide; 
a, ALF/serum urea x lOO= ELF% (10); ELF, epithelial lining fluid. 
Table 9 Means f standard errors of means of total cells and differentials in cytocentrifuge 
preparations in three series of ‘alveolar’ lavages of normal volunteers 
Reference 
Total cells Macrophages Lymphocytes Neutrophils 
n x 1061-’ “/;I x 1061-’ ‘% x 1061-’ % x 1061-’ 
Rennard (2) 18 1453~15 81*2 12*2 3 It 0.4 
van Vyve (3) 31 146zk13 77~k3 8Oi 10 7fl 8*3 5*1 612 
Present study 18 108&17 85*2 85 i 2 13zk2 13 f 3 2io.5 2 f 0.4 
not essentially differ from those in our series (Table 
9), although the study subjects were derived from 
ethnically very different populations. 
The distribution of common lymphocyte surface 
markers in this study (Table 4) was fairly similar to 
that obtained by immunoperoxidase slide assay (18). 
Our method however, is less tedious and time con- 
suming, and the staining may be automated. In 
economy the present method competes favourably 
with flow cytometry if the total amount of lavage 
specimens is not very large. According to our experi- 
ence, expressing the results as the number of cells per 
volume of ALF is more meaningful than mere per- 
centage in evaluating the activity of alveolitis in 
sarcoidosis (19). Thus, these values are also given for 
normal controls (Table 5). 
It has been stated recently that, regarding the 
quantitation of soluble components, BAL still repre- 
sents a technical dilemma (10). According to our 
experience, however, the concentrations of several 
proteins in ALF from patients with interstitial lung 
diseases, especially from those with active alveolitis 
of sarcoidosis, exceed the range of the same from 
healthy controls (11,12). We therefore think that, 
regardless of all limitations, reference values with 
confidence limits should be published for most 
important solutes in ALF recovered using a standard 
technique, so that the role of the method in detecting 
disease states could be evaluated. In fact, Rennard 
et al. (2) have measured the concentrations of 
selected proteins in bronchial and alveolar samples 
of BALF in a group consisting of both healthy 
volunteers and patients, but have not published the 
data separately. According to the technical rec- 
ommendation of the European Task Group on BAL 
(4), the first aliquot recovered should be analysed 
separately. Thus, if the recommendation is followed, 
ALF should be studied instead of BALF. Neverthe- 
less, the reference values published so far have been 
determined on pooled BALF (4,20). 
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